Skip to content

Opinion

NACDS remains the industry’s hub

Chain drug retailing has changed dramatically in the first decade of the 21st century. Nowhere have those changes been more evident than in the character and content of the National Association of Chain Drug Stores.

Walgreens’ makeover a game-changing event

The year that just ended has seen the Walgreen Co. transform itself more suddenly, dramatically and, to some observers, inexplicably than any mass retailer in the industry’s annals. Go back to the last months of 2007. Walgreens was hardly a focus of undue industry attention.

NACDS is hub of chain drug industry

For four days at the beginning of December, NACDS brought the chain drug industry briefly to life, by the simple expedient of gathering the retailer and supplier communities together in New York City for a series of business and social events.

What science-based guidelines mean for Rx

Retail pharmacy operators and other health care providers recently were given a preview of the difficulties involved in implementing the findings of comparative effectiveness research, a science-based approach to evaluating the benefits and potential dangers of alternative forms of diagnosis and tre

Coalition shines light on medication adherence

The day before the Senate leadership unveiled an $848 billion bill that will be the focal point of the next phase of the health care reform debate, all of the members of Congress received a timely reminder about the importance of including measures to improve medication compliance in whatever legisl

Rx’s role in health care reform

Tom Ryan brings his customary concentration of thought and clarity of purpose to the issue of health care reform in an op-ed piece that recently appeared in The Washington Times.

CVS, Walgreens should seize moment

CVS Caremark and Walgreens both opened their 7,000th drug store earlier this fall, within a week of each other. CVS’ milestone store opened in a suburb of St. Paul, while Walgreens’ landmark unveiling took place in the Coney Island section of Brooklyn, N.Y.

There’s plenty of reason to be bullish about Rx

Everywhere community pharmacy operators turn these days there seems to be a new challenge. Over the weekend, chain drug stores and other prescription drug providers began to feel the fallout from the reduction in average wholesale prices mandated by the settlement of a class-action lawsuit.